Citation Impact
Citing Papers
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
2016
Optical coherence tomography angiography
2017 Standout
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
2004
Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
2012
Anti-vascular endothelial growth factor for diabetic macular oedema
2014
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
2012
Diabetic retinopathy
2010 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
The Neovascular Age-Related Macular Degeneration Database
2014
An Active Contour Model for Segmenting and Measuring Retinal Vessels
2009
Age-Related Macular Degeneration
2008 Standout
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy
2009
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning
2018 Standout
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
Update on nonsurgical therapy for diabetic macular edema
2011
Transport Barriers in Transscleral Drug Delivery for Retinal Diseases
2007
Ocular drug delivery
2006
Inflammation in diabetic retinopathy
2011
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
2012
Ocular Drug Delivery
2010 Standout
The role of inflammation in diabetic eye disease
2019
Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery
2009
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization
2016 StandoutNobel
Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study
2008
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Ranibizumab in diabetic macular edema
2013
Management of Diabetic Retinopathy
2007
Age-related macular degeneration
2012 Standout
Ten years of anti-vascular endothelial growth factor therapy
2016
Diabetic Retinopathy
2012 Standout
REVIEW ARTICLE, Immunological Factors in the Pathogenesis and Treatment of Age-Related Macular Degeneration
2005
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
2021 Standout
Analysis of Macular Edema after Cataract Surgery in Patients with Diabetes Using Optical Coherence Tomography
2007
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Automated Analysis of Retinal Images for Detection of Referable Diabetic Retinopathy
2013
INTRAVITREAL BEVACIZUMAB PLUS GRID LASER PHOTOCOAGULATION OR INTRAVITREAL BEVACIZUMAB OR GRID LASER PHOTOCOAGULATION FOR DIFFUSE DIABETIC MACULAR EDEMA
2012
Diabetic Macular Edema
2012
Age-related macular degeneration
2018 Standout
Exploratory Analysis of the Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial
2013
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study
2016
Aging and vision
2010 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
Emerging drugs for diabetic retinopathy
2008
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
2017 StandoutNobel
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age‐Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
2016 Standout
Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
2014
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
2013
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results
2014
Ranibizumab for Diabetic Macular Edema
2012 Standout
Etiology and Treatment of Macular Edema
2008
Risk factors and biomarkers of age-related macular degeneration
2016
Combined Laser and Intravitreal Triamcinolone for Proliferative Diabetic Retinopathy and Macular Edema: One-year Results of a Randomized Clinical Trial
2008
Pegaptanib for Neovascular Age-Related Macular Degeneration
2004 Standout
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
2015
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
2016
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Artificial intelligence in healthcare
2018 Standout
Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema
2009
Inflammation in obesity, diabetes, and related disorders
2022 Standout
An Ensemble Classification-Based Approach Applied to Retinal Blood Vessel Segmentation
2012 Standout
Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element
2008
Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
2012
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
2009
When to use the B onferroni correction
2014 Standout
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Peroxisome Proliferator-Activated Receptor-β/δ Regulates Angiogenic Cell Behaviors and Oxygen-Induced Retinopathy
2013
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Intravitreal steroids for macular edema in diabetes
2008
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
2016 StandoutNobel
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium*
2008
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
2018
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Critical Success Factors of the Project Management in Relation to Industry 4.0 for Sustainability of Projects
2020 Standout
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
2017
Solar-driven interfacial evaporation
2018 Standout
A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema
2008
Oligocone Trichromacy: Clinical and Molecular Genetic Investigations
2010
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States
2014
Sustainability Outcomes of Green Processes in Relation to Industry 4.0 in Manufacturing: Systematic Review
2020
Concentrating Solar Power
2015
A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema
2012
Research opportunities to advance solar energy utilization
2016 StandoutScience
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
2010
In Vivo Ocular Efficacy Profile of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Rabbit Models of Ocular Disease
2010
Systems biology of oxygen homeostasis
2017 StandoutNobel
Abnormalities of Retinal Microvascular Structure and Risk of Mortality From Ischemic Heart Disease and Stroke
2006
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Emerging Pharmacotherapies for Diabetic Macular Edema
2012
Diabetic retinopathy management guidelines
2012
Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index
2012
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 Standout
The Impact of Implementing Talent Management Practices on Sustainable Organizational Performance
2020 Standout
Works of Florian Sutter being referenced
Interim (3 month) Analysis of the Safety of Intravitreal Triamcinolone for Diabetic Macular Oedema that Persists after Laser Treatment. Results from a Randomized Clinical Trial: TDMO
2003
Interim (3 month) Analysis of the Efficacy of Intravitreal Triamcinolone for Diabetic Macular Oedema that Persists after Laser Treatment. A Randomized Clinical Trial: TDMO
2003
A Randomized, Placebo–Controlled Trial of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema That Persists or Recurs After Laser Treatment – 2–Year Results
2005
Familial Retinal Arteriolar Tortuosity: A Review
2003
Relation Between Reduction of Foveal Thickness and Visual Acuity in Diabetic Macular Edema Treated With Intravitreal Triamcinolone
2005
Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema
2013
Intravitreal Triamcinolone for Refractory Diabetic Macular EdemaTwo-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial
2006
Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism
2006
Pseudo-endophthalmitis after intravitreal injection of triamcinolone
2003
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatmentThree-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial
2004
Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo‐controlled, clinical trial
2008
The RESTORE Study
2011
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
2009
Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
2012
Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?
2007
A Review of Conventional and Innovative- Sustainable Methods for Cleaning Reflectors in Concentrating Solar Power Plants
2018
Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD
2011
Development of a spatially resolved reflectometer to monitor corrosion of solar reflectors
2013